|
|
|
|
|
Received: 25 December 2014
|
|
|
|
|
|
| [7] |
Kohno N, Kyoizumi S, Awaya Y, et al. New serum indicator of interstitial pneumonitis activity. Sialylated carbohydrate antigen KL-6[J]. Chest, 1989, 96: 68-73.
|
| [1] |
Raghu G, Weycker D, Edelsberg J, et al. Incidence and prevalence of idiopathic pulmonary fibrosis [J]. Am J Respir Crit Care Med, 2006, 174(7): 810-816.
|
| [2] |
Kim D S, Collard H R, King T E Jr. Classification and natural history of the idiopathic interstitial pneumonias [J]. Proc Am Thorac Soc, 2006, 3(4): 285-292.
|
| [8] |
Hesselstrand R, Wildt M, Bozovic G, et al. Biomarkers from bronchoalveolar lavage fluid in systemic sclerosis patients with interstitial lung disease relate to severity of lung fibrosis [J]. Respir Med, 2013, 107(7): 1079-1086.
|
| [9] |
徐伯赢, 张 慧, 徐菊玲, 等. 染矽小鼠体内KL-6含量与肺纤维化关系 [J]. 中国公共卫生, 2014, 30(12): 1536-1538.
|
| [3] |
Ryerson C J, Hartman T, Elicker B M, et al. Clinical features and outcomes in combined pulmonary fibrosis and emphysema in idiopathic pulmonary fibrosis [J]. Chest, 2013, 144(1): 234-240.
|
| [10] |
Huang H, Peng X, Nakajima J. Adances in the study of biomarkers of idiopathic pulmonary fibrosis in Japan [J]. Biosci Trends, 2013, 7(4): 172-177.
|
| [4] |
Raghu G, Collard H R, Egan J J, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management [J]. Am J Respir Crit Care Med, 2011, 183(6): 788-824.
|
| [11] |
韩文铭, 黄 燕, 刘 一. 血清KL-6检测在COPD合并肺间质纤维化诊断中的意义 [J]. 中国工业医学杂志, 2006, 19(1): 11-121.
|
| [5] |
Ishii H, Mukae H, Kadota J, et al. High serum concentrations of surfactant protein A in usual interstitial pneumonia compared with non-specific interstitial pneumonia [J]. Thorax, 2003,58:52-54.
|
| [12] |
Nobuhisa I, Noboru H, Akihito Y,et al. Utility of KL-6/MUC1 in the clinical management of interstitial lung diseases [J]. Respir Investig, 2012, 50(1): 3-13.
|
| [6] |
Ichiyasu H, Ichikado K, Yamashita A, et al. Pneumocyte biomarkers KL-6 and surfactant protein D reflect the distinct findings of high-resolution computed tomography in nonspecific interstitial pneumonia [J]. Respiration, 2012,83:190-197.
|
| [13] |
Shukla M N, Rose J L, Ray R, et al. Hepatocyte growth factor inhibits epithelial to myofibroblast transition in lung cells via Smad7 [J]. Am J Respir Cell Mol Biol, 2009, 40(6): 643-653.
|
| [14] |
Xu L, Yan D R, Zhu S L, et al. KL-6 regulated the expression of HGF, collagen and myofibroblast differentiation [J]. Eur Rev Med Pharmacol Sci, 2013, 17(22): 3073-3077.
|
| [15] |
Ohshimo S, Ishikawa N,Horimasu Y,et al. Baseline KL-6 predicts increased risk for acute exacerbation of idiopathic pulmonary fibrosis [J]. Respir Med, 2014, 108(7): 1031-1039.
|
| [16] |
徐 倩,吴祖群,王 凯.YKL-40(BRP-39)与支气管哮喘 [J]. 中华哮喘杂志, 2012, 6(3): 34-37.
|
| [7] |
Kohno N, Kyoizumi S, Awaya Y, et al. New serum indicator of interstitial pneumonitis activity. Sialylated carbohydrate antigen KL-6[J]. Chest, 1989, 96: 68-73.
|
| [17] |
Du C, Yang Y, Lin Y, et al. Expression and mechanism of BRP-39 in bleomycin-induced pulmonary fibrosis in rat [J]. Cell Biochem Biophys, 2014, 70(1): 251-257.
|
| [8] |
Hesselstrand R, Wildt M, Bozovic G, et al. Biomarkers from bronchoalveolar lavage fluid in systemic sclerosis patients with interstitial lung disease relate to severity of lung fibrosis [J]. Respir Med, 2013, 107(7): 1079-1086.
|
| [9] |
徐伯赢, 张 慧, 徐菊玲, 等. 染矽小鼠体内KL-6含量与肺纤维化关系 [J]. 中国公共卫生, 2014, 30(12): 1536-1538.
|
| [18] |
Furuhashi K, Suda T, Nakamura Y, et al. Increased expression of YKL-40, a chitinase-like protein, in serum and lung of patients with idiopathic pulmonary fibrosis [J]. Respir Med, 2010, 104: 1204-1210.
|
| [10] |
Huang H, Peng X, Nakajima J. Adances in the study of biomarkers of idiopathic pulmonary fibrosis in Japan [J]. Biosci Trends, 2013, 7(4): 172-177.
|
| [11] |
韩文铭, 黄 燕, 刘 一. 血清KL-6检测在COPD合并肺间质纤维化诊断中的意义 [J]. 中国工业医学杂志, 2006, 19(1): 11-121.
|
| [19] |
Samukawa T, Hamada T, Uto H, et al. The elevation of serum napsin A in idiopathic pulmonary fibrosis, compared with KL-6, surfactant protein-A and surfactant protein-D [J]. BMC Pulm Med, 2012, 12: 55-62.
|
| [12] |
Nobuhisa I, Noboru H, Akihito Y,et al. Utility of KL-6/MUC1 in the clinical management of interstitial lung diseases [J]. Respir Investig, 2012, 50(1): 3-13.
|
| [20] |
Song J W, Do K H, Jang S J, et al. Blood biomarkers MMP-7 and SP-A: predictors of outcome in idiopathic pulmonary fibrosis [J]. Chest, 2013, 143(5): 1422-1429.
|
| [13] |
Shukla M N, Rose J L, Ray R, et al. Hepatocyte growth factor inhibits epithelial to myofibroblast transition in lung cells via Smad7 [J]. Am J Respir Cell Mol Biol, 2009, 40(6): 643-653.
|
| [14] |
Xu L, Yan D R, Zhu S L, et al. KL-6 regulated the expression of HGF, collagen and myofibroblast differentiation [J]. Eur Rev Med Pharmacol Sci, 2013, 17(22): 3073-3077.
|
| [21] |
Zhang H, Wang R, Wang H, et al. Dynamic changes in expression of clara cell protein and surfactant protein-D expressions in lung tissues and bronchoalveolar lavage fluid of silica-treated rats [J]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, 2014, 32(3): 168-172.
|
| [22] |
陈淑云,顾文刚,于 莉. 联合检测血清肿瘤标志物对非小细胞肺癌的诊断价值 [J]. 武警医学, 2013, 24(10): 887-889.
|
| [15] |
Ohshimo S, Ishikawa N,Horimasu Y,et al. Baseline KL-6 predicts increased risk for acute exacerbation of idiopathic pulmonary fibrosis [J]. Respir Med, 2014, 108(7): 1031-1039.
|
| [23] |
Woenckhaus M, Merk J, Stoehr R, et al. Prognostic value of FHIT, CTNNBI and MUC1 expression in non-small cell lung cancer [J]. Hum Pathol, 2008, 39(1): 126-136.
|
| [16] |
徐 倩,吴祖群,王 凯.YKL-40(BRP-39)与支气管哮喘 [J]. 中华哮喘杂志, 2012, 6(3): 34-37.
|
| [17] |
Du C, Yang Y, Lin Y, et al. Expression and mechanism of BRP-39 in bleomycin-induced pulmonary fibrosis in rat [J]. Cell Biochem Biophys, 2014, 70(1): 251-257.
|
| [24] |
Them I, Andritzky B, Schuch G, et al. Elevated pre-treatment serum concentration of YKL-40-An independent prognostic biomarker for poor survival in patients with metastatic non-small cell lung cancer [J]. Cancer, 2010, 116(17): 4114-4121.
|
| [18] |
Furuhashi K, Suda T, Nakamura Y, et al. Increased expression of YKL-40, a chitinase-like protein, in serum and lung of patients with idiopathic pulmonary fibrosis [J]. Respir Med, 2010, 104: 1204-1210.
|
| [19] |
Samukawa T, Hamada T, Uto H, et al. The elevation of serum napsin A in idiopathic pulmonary fibrosis, compared with KL-6, surfactant protein-A and surfactant protein-D [J]. BMC Pulm Med, 2012, 12: 55-62.
|
| [20] |
Song J W, Do K H, Jang S J, et al. Blood biomarkers MMP-7 and SP-A: predictors of outcome in idiopathic pulmonary fibrosis [J]. Chest, 2013, 143(5): 1422-1429.
|
| [21] |
Zhang H, Wang R, Wang H, et al. Dynamic changes in expression of clara cell protein and surfactant protein-D expressions in lung tissues and bronchoalveolar lavage fluid of silica-treated rats [J]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, 2014, 32(3): 168-172.
|
| [22] |
陈淑云,顾文刚,于 莉. 联合检测血清肿瘤标志物对非小细胞肺癌的诊断价值 [J]. 武警医学, 2013, 24(10): 887-889.
|
| [23] |
Woenckhaus M, Merk J, Stoehr R, et al. Prognostic value of FHIT, CTNNBI and MUC1 expression in non-small cell lung cancer [J]. Hum Pathol, 2008, 39(1): 126-136.
|
| [24] |
Them I, Andritzky B, Schuch G, et al. Elevated pre-treatment serum concentration of YKL-40-An independent prognostic biomarker for poor survival in patients with metastatic non-small cell lung cancer [J]. Cancer, 2010, 116(17): 4114-4121.
|
|
|
2015, Vol. 26 
